162 related articles for article (PubMed ID: 9280606)
1. [Clinical application of interleukin-6 receptor antibody].
Nishimoto N; Shima Y; Sasai M; Danno N; Yoshizaki K
Nihon Rinsho Meneki Gakkai Kaishi; 1997 Apr; 20(2):87-94. PubMed ID: 9280606
[TBL] [Abstract][Full Text] [Related]
2. [Effect of humanized anti-interleukin-6 receptor antibody on new xenograft model of multiple myeloma].
Shimazaki C; Goto H
Rinsho Ketsueki; 1997 Apr; 38(4):281-4. PubMed ID: 9146051
[No Abstract] [Full Text] [Related]
3. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.
Nishimoto N; Sasai M; Shima Y; Nakagawa M; Matsumoto T; Shirai T; Kishimoto T; Yoshizaki K
Blood; 2000 Jan; 95(1):56-61. PubMed ID: 10607684
[TBL] [Abstract][Full Text] [Related]
4. Anti-interleukin 6 receptor antibody treatment in rheumatic disease.
Nishimoto N; Kishimoto T; Yoshizaki K
Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i21-7. PubMed ID: 11053081
[TBL] [Abstract][Full Text] [Related]
5. Constituents of autocrine IL-6 loops in myeloma cell lines and their targeting for suppression of neoplastic growth by antibody strategies.
Villunger A; Egle A; Kos M; Hittmair A; Maly K; Greil R
Int J Cancer; 1996 Feb; 65(4):498-505. PubMed ID: 8621234
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of IL-6 for the treatment of inflammatory diseases.
Nishimoto N; Kishimoto T
Curr Opin Pharmacol; 2004 Aug; 4(4):386-91. PubMed ID: 15251133
[TBL] [Abstract][Full Text] [Related]
7. Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan.
Nishimoto N
Clin Rev Allergy Immunol; 2005 Jun; 28(3):221-30. PubMed ID: 16129906
[TBL] [Abstract][Full Text] [Related]
8. New xenograft model of multiple myeloma and efficacy of a humanized antibody against human interleukin-6 receptor.
Tsunenari T; Koishihara Y; Nakamura A; Moriya M; Ohkawa H; Goto H; Shimazaki C; Nakagawa M; Ohsugi Y; Kishimoto T; Akamatsu K
Blood; 1997 Sep; 90(6):2437-44. PubMed ID: 9310495
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6: structure-function relationships.
Simpson RJ; Hammacher A; Smith DK; Matthews JM; Ward LD
Protein Sci; 1997 May; 6(5):929-55. PubMed ID: 9144766
[TBL] [Abstract][Full Text] [Related]
10. [Anti-interleukin-6 receptor antibody therapy--from bedside to bench].
Nishimoto N
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Oct; 29(5):289-94. PubMed ID: 17075187
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of humanized anti-interleukin-6 receptor antibody: antitumor activity in xenograft model of multiple myeloma.
Tsunenari T; Akamatsu K; Kaiho S; Sato K; Tsuchiya M; Koishihara Y; Kishimoto T; Ohsugi Y
Anticancer Res; 1996; 16(5A):2537-44. PubMed ID: 8917348
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 receptor expression in the peripheral B cells of patients with multicentric Castleman's disease.
Ishiyama T; Koike M; Nakamura S; Kakimoto T; Akimoto Y; Tsuruoka N
Ann Hematol; 1996 Oct; 73(4):179-82. PubMed ID: 8890706
[TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy using IL-6 receptor as the target].
Nishimoto N
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):399-404. PubMed ID: 18974624
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 6: from bench to bedside.
Nishimoto N; Kishimoto T
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):619-26. PubMed ID: 17075601
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapeutic implication of IL-6 blockade.
Tanaka T; Kishimoto T
Immunotherapy; 2012 Jan; 4(1):87-105. PubMed ID: 22150003
[TBL] [Abstract][Full Text] [Related]
16. The paradigm of IL-6: from basic science to medicine.
Naka T; Nishimoto N; Kishimoto T
Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S233-42. PubMed ID: 12110143
[TBL] [Abstract][Full Text] [Related]
17. The blockade of IL-6 signaling in rational drug design.
Adachi Y; Yoshio-Hoshino N; Nishimoto N
Curr Pharm Des; 2008; 14(12):1217-24. PubMed ID: 18473869
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death.
Demartis A; Bernassola F; Savino R; Melino G; Ciliberto G
Cancer Res; 1996 Sep; 56(18):4213-8. PubMed ID: 8797594
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to rat soluble IL-6 receptor stimulate B9 hybridoma cell proliferation.
Thibault V; Richards CD; Botelho F; Gauldie J
FEBS Lett; 1997 May; 408(2):182-6. PubMed ID: 9187363
[TBL] [Abstract][Full Text] [Related]
20. [Advances in interleukin-6 therapy].
Ogata A; Nishimoto N; Yoshizaki K
Rinsho Byori; 1999 Apr; 47(4):321-6. PubMed ID: 10340005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
